Validity and Reliability of the Alzheimer’s Disease Cooperative Study-Clinical Global Impression of Change (ADCS-CGIC)
Clinical global impressions of change (CGICs) are important measures of efficacy in clinical trials. CGIC scales have been used extensively as primary outcome criteria in psychopharmacological trials and in early clinical trials for antidementia drugs (e.g., Schneider and Olin, 1994). CGICs have been reported to be the most sensitive index of change in 14 of 17 dementia trials, when compared to other measures (Lehmann, 1984).
Unable to display preview. Download preview PDF.
- Clinical Global Impressions (CGI) (1976): In: ECDEU Assessment Manual for Psychopharmacology, Guy W, ed. Rockville, MD: U.S. Department of Health and Human Services, Public Health Service, Alcohol Drug Abuse and Mental Health Administration, NIMH Psychopharmacology Research Branch, pp. 218–222.Google Scholar
- Leber P. (November, 1991): Unpublished letter to pharmaceutical companies [Issues affecting the implementation of the Clinician’s Global Assessment].Google Scholar
- Olin JT, Clark C, Doody R, Schmitt F, Ferris S, Morris J, Reisberg B, Schneider LS (1996): Reliability and validity of a new clinical global rating scale for Alzheimer’s clinical trials. J Int Neuropsychol Soc 2:4Google Scholar
- Reisberg B (1988): Functional assessment staging (FAST). Psyehopharmaeol Bull 24:653–659.Google Scholar
- Schneider LS, Olin JT (1996): Clinical Global Impressions in Clinical Trials. Int. Psychogeriat (In Press)Google Scholar
- Schneider LS, Olin JT, Doody RS, Clark CM, Morris JC, Reisberg B, Schmitt FA, Grundman M, Thomas RG, Ferris SH (1996): Validity and reliability of the Alzheimer’s Disease Study-Clinical Global Impression of Change (ADCS-CGIC). Alzheimer’s Disease and Associated Disorders. (In Press,)Google Scholar